Vivani reported Phase 1 success for its exenatide implant and shared preclinical semaglutide data showing 231-day weight loss ...

Overview: Vivani Medical, Inc. is a clinical-stage biopharmaceutical company focused on developing miniaturized and subdermal drug implants for treating chronic diseases, with a market cap of $88. ...

Get the detailed quarterly/annual income statement for Vivani Medical, Inc. (VANI). Find out the revenue, expenses and profit or loss over the last fiscal year.

Stay up to date on how Vivani Medical Inc (VANI:XNAS) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.

Cash Flow Statement for Vivani Medical Inc, company's cash and cash equivalents, broken down to operating, investing and financing activities.